Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3826 participants.
Also called NCT07349875
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,826 participants
- Registry
-
NCT07349875
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07349875. Randomized; single masking; primary purpose treatment. Start 2026-01-01 (actual); primary completion 2029-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
- Acronym
- COLOR
- Intervention (Drug)
- Colchicine combined with Guideline-Directed Medical Therapy
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
Record details
- Record id
cardio:ct-nct07349875- Content hash
465fd306cb4b48bee339903f833cbd13ff189917a606f72e33ea04ff83f38193